FULGENT GENETICS, INC. Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff
FULGENT GENETICS, INC. (FLGT) reported Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Allowance for Credit Loss
us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossWriteoff · last filed 2026-02-27
- FULGENT GENETICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for the quarter ending 2024-12-31 was -$20.15M.
- FULGENT GENETICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for fiscal 2025 was $0.00.
- FULGENT GENETICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for fiscal 2024 was -$10.07M.
- FULGENT GENETICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for fiscal 2023 was $0.00.
- FULGENT GENETICS, INC. debt securities, available-for-sale, allowance for credit loss, writeoff for fiscal 2022 was $0.00.
| Period end | Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff 3 month | Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff 9 month | Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 | ||
| 2024-12-31 | -$20.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$10.07M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $10.07M 10-Q · filed 2024-11-08 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | ||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |